116 related articles for article (PubMed ID: 37602474)
1. NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis.
Wang Z; Tao E; Chen Y; Wang Q; Liu M; Wei L; Xu S; Chen W; Zhong C
Biochem Cell Biol; 2023 Dec; 101(6):523-530. PubMed ID: 37602474
[TBL] [Abstract][Full Text] [Related]
2. NDUFA4 promotes cell proliferation by enhancing oxidative phosphorylation in pancreatic adenocarcinoma.
Zhang Y; Ge M; Chen Y; Yang Y; Chen W; Wu D; Cai H; Chen X; Wu X
J Bioenerg Biomembr; 2022 Dec; 54(5-6):283-291. PubMed ID: 36307669
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MIF-AS1 promotes gastric cancer cell proliferation and reduces apoptosis to upregulate NDUFA4.
Li L; Li Y; Huang Y; Ouyang Y; Zhu Y; Wang Y; Guo X; Yuan Y; Gong K
Cancer Sci; 2018 Dec; 109(12):3714-3725. PubMed ID: 30238562
[TBL] [Abstract][Full Text] [Related]
4. High throughput proteomic and metabolic profiling identified target correction of metabolic abnormalities as a novel therapeutic approach in head and neck paraganglioma.
Wang Z; Chen H; Xue L; He W; Shu W; Wu H; Wang Z
Transl Oncol; 2021 Aug; 14(8):101146. PubMed ID: 34118692
[TBL] [Abstract][Full Text] [Related]
5. miR-147 Represses NDUFA4, Inducing Mitochondrial Dysfunction and Tubular Damage in Cold Storage Kidney Transplantation.
Zhu J; Xiang X; Hu X; Li C; Song Z; Dong Z
J Am Soc Nephrol; 2023 Aug; 34(8):1381-1397. PubMed ID: 37211637
[TBL] [Abstract][Full Text] [Related]
6. m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer.
Xu W; Lai Y; Pan Y; Tan M; Ma Y; Sheng H; Wang J
Cell Death Dis; 2022 Aug; 13(8):715. PubMed ID: 35977935
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in the NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4 (
Yagil C; Varadi-Levi R; Yagil Y
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30361421
[TBL] [Abstract][Full Text] [Related]
8. Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells.
Florio R; De Lellis L; Veschi S; Verginelli F; di Giacomo V; Gallorini M; Perconti S; Sanna M; Mariani-Costantini R; Natale A; Arduini A; Amoroso R; Cataldi A; Cama A
Sci Rep; 2018 Sep; 8(1):13610. PubMed ID: 30206358
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
Cui S; Yang X; Zhang L; Zhao Y; Yan W
Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529
[TBL] [Abstract][Full Text] [Related]
10. Effects of PPARα inhibition in head and neck paraganglioma cells.
Florio R; De Lellis L; di Giacomo V; Di Marcantonio MC; Cristiano L; Basile M; Verginelli F; Verzilli D; Ammazzalorso A; Prasad SC; Cataldi A; Sanna M; Cimini A; Mariani-Costantini R; Mincione G; Cama A
PLoS One; 2017; 12(6):e0178995. PubMed ID: 28594934
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
12. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
Kim EH; Shin D; Lee J; Jung AR; Roh JL
Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
[TBL] [Abstract][Full Text] [Related]
14. NDUFA4 is a subunit of complex IV of the mammalian electron transport chain.
Balsa E; Marco R; Perales-Clemente E; Szklarczyk R; Calvo E; Landázuri MO; Enríquez JA
Cell Metab; 2012 Sep; 16(3):378-86. PubMed ID: 22902835
[TBL] [Abstract][Full Text] [Related]
15. Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3.
Hu Z; Zhao Y; Li L; Jiang J; Li W; Mang Y; Gao Y; Dong Y; Zhu J; Yang C; Ran J; Li L; Zhang S
Mol Biol Rep; 2023 Aug; 50(8):6399-6413. PubMed ID: 37326750
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
17. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
Yang J; Zhou Y; Xie S; Wang J; Li Z; Chen L; Mao M; Chen C; Huang A; Chen Y; Zhang X; Khan NUH; Wang L; Zhou J
J Exp Clin Cancer Res; 2021 Jun; 40(1):206. PubMed ID: 34162423
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas.
Zhi Y; Gerhard-Hartmann E; Hartrampf PE; Weich A; Higuchi T; Bley TA; Hackenberg S; Hagen R; Rosenwald A; Scherzad A; Remde H; Fassnacht M; Werner RA; Serfling SE
Clin Nucl Med; 2023 Nov; 48(11):923-927. PubMed ID: 37756444
[TBL] [Abstract][Full Text] [Related]
19. Metformin improved oxidized low-density lipoprotein-impaired mitochondrial function and increased glucose uptake involving Akt-AS160 pathway in raw264.7 macrophages.
He X; Wang L; Chen XF; Liang Q; Wang WQ; Lin AQ; Yi L; Wang Y; Gao Q
Chin Med J (Engl); 2019 Jul; 132(14):1713-1722. PubMed ID: 31268904
[TBL] [Abstract][Full Text] [Related]
20. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
